Sfoglia per Rivista  

Opzioni
Vai a: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Mostrati risultati da 38 a 57 di 199
Titolo Data di pubblicazione Autori Tipo File Abstract
Consensus statements on vaccination in patients with haemophilia—results from the italian haemophilia and vaccinations (Heva) project 2019 Riva A.Esposito S.Mazzucchelli R. I.Clerici M. + Article (author) -
Current European practice in immune tolerance induction therapy in patients with haemophilia and inhibitors 2006 A. Gringeri + Article (author) -
Current use of by-passing agents in Europe in the management of acute bleeds in patients with haemophilia and inhibitors 2007 A. Gringeri + Article (author) -
Delivery of AAV-based gene therapy through haemophilia centres—A need for re-evaluation of infrastructure and comprehensive care: A Joint publication of EAHAD and EHC 2021 Peyvandi F. + Article (author) -
Desmopressin : an historical introduction 2008 P.M. Mannucci Article (author) -
Differences between patients', physicians' and pharmacists' preferences for treatment products in haemophilia : a discrete choice experiment 2005 A. GringeriL. ScaloneP.M. MannucciM.S. MonziniL.G. Mantovani + Article (author) -
Differential diagnosis between type 2A and 2B von Willebrand disease in a child with a previously undescribed de novo mutation 2018 PAGLIARI, MARIA TERESABaronciani, L.Siboni, S. M.Payvandi, F. + Article (author) -
Does the orphan medicinal product regulation assist or hinder access to innovative haemophilia treatment in Europe ? 2014 F. Peyvandi + Article (author) -
The dominant p.Thr274Pro mutation in the von Willebrand factor propeptide causes the von Willebrand disease type 1 phenotype in two unrelated patients 2022 Pagliari M. T.Baronciani L.Cozzi G.Siboni S. M.Peyvandi F. + Article (author) -
The effect of emicizumab prophylaxis on health-related outcomes in persons with haemophilia A with inhibitors: HAVEN 1 Study 2019 Peyvandi, Flora + Article (author) -
Effects of secondary prophylaxis started in adolescent and adult haemophiliacs 2008 P.M. Mannucci + Article (author) -
Efficacy and safety during formulation switch of a pasteurized VWF/FVIII concentrate : results from an Italian prospective observational study in patients with von Willebrand disease 2013 A.B. Federici + Article (author) -
Efficacy and safety of a VWF/FVIII concentrate (wilate®) in inherited von Willebrand disease patients undergoing surgical procedures 2017 Peyvandi, Flora + Article (author) -
Efficacy and safety of fibrinogen concentrate for on-demand treatment of bleeding and surgical prophylaxis in paediatric patients with congenital fibrinogen deficiency 2020 Peyvandi F. + Article (author) -
Efficacy and safety of highly purified, doubly virus-inactivated VWF/FVIII concentrates in inherited von Willebrand's disease : results of an Italian cohort study on 120 patients characterized by bleeding severity score 2010 A.B. FedericiP.M. Mannucci + Article (author) -
Efficacy of prophylaxis and genotype-phenotype correlation in patients with severe Factor X deficiency in Iran 2012 M. MenegattiF. Peyvandi + Article (author) -
Efficacy, safety and pharmacokinetics of a new high-purity factor X concentrate in subjects with hereditary factor X deficiency 2016 F. Peyvandi + Article (author) -
Emerging and re-emerging infections at the turn of the millennium 2010 A.R. ZanettiA. Zappa Article (author) -
Epidemiology and general guidelines of the management of acquired haemophilia and von Willebrand syndrome 2008 FEDERICI, AUGUSTO BRAMANTE + Article (author) -
European principles of haemophilia care 2008 A. Gringeri + Article (author) -
Mostrati risultati da 38 a 57 di 199
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile